Novartis Raises FullYear Sales and Profit Guidance Amid Strong Drug Performance Microsofts New Trusted Technology Lead Jenny LayFlurrie Navigates Tension Between AI Speed and Responsibility Yankees Aaron Judge Concerns Managements Brief Response Signals Steady Approach Fed Dissenters Cite Disagreement Over Rate Cut Signals in Latest Vote Market Expert Raja Venkatraman Highlights Three Stock Picks for Trading Opportunities Amazon Faces Allegations Over Previously Legal Policy That Generated Millions LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat TrueBlue Inc Q1 2026 Earnings EPS Surprises Above Estimates Despite Negative Earnings PowerFleet AIOT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction TBLA Q1 2026 Earnings EPS Beats Estimates by 68 as Shares Edge Lower UZD Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Performance NAVI Q1 2026 Earnings EPS Beat Drives Positive Stock Response eXoZymes Inc EXOZ Surges 55 Key Levels to Watch After the Rally Actinium Pharmaceuticals ATNM Modest Gain Above Support as Biotech Stock Holds Key Level CCID Preferred Shares Edge Lower Key Support and Resistance Levels in Play Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten ASPCR Plunges 3289 A SPAC III Acquisition Corp Right Faces Heavy Selling Pressure Major Brokerage Platforms Offer Retail Investors Direct Access to SpaceX IPO KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin DiaMedica Therapeutics DMAC Gains 243 as Buyers Defend Key Support